Document is current

Any future updates will be listed below

Artificial intelligence and machine learning based discovery of bioisosteres (BIOS) of FDA approved MAO-B inhibitors for the management of Alzheimer’s disease

Crossref DOI link: https://doi.org/10.1007/s44371-026-00634-4

Published Online: 2026-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark